Streetbeat News

Stock Prices

FRSH

Freshworks (NASDAQ:FRSH) reported Q2 2024 adjusted EPS of $0.08, beating the $0.06 estimate by 33.33%. Sales were $174.131M, surpassing the $171.071M estimate by 1.79%. This represents a 14.29% increase in EPS and a 20.02% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:12 pm

SYK

Stryker has updated its FY24 EPS guidance to $11.90-$12.10, slightly below the $11.95 estimate. The company anticipates a moderately unfavorable impact on net sales due to foreign exchange rates, affecting adjusted net EPS by $0.10-$0.15. Despite this, Stryker expects organic net sales growth of 9.0%-10.0% with a favorable pricing impact of 0.5%.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:12 pm

INFA

Informatica shares are trading lower after the company reported worse-than-expected Q2 sales results.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:12 pm

PINS

Pinterest has provided its Q3 2024 revenue guidance, estimating between $885 million and $900 million, which is lower than the $907.7 million it saw previously.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:11 pm

RCKY

Rocky Brands (NASDAQ:RCKY) reported Q2 2024 adjusted EPS of $0.17, beating the estimate of $0.10 by 70%. Sales were $98.258M, surpassing the $96.450M estimate but down 1.57% from last year's $99.822M.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:11 pm

PSA

Public Storage has provided its 2024 financial outlook, projecting a decline in same-store revenue growth between (1.5)% and (0.5)%, while expecting same-store expense growth to range from 2.0% to 3.5%.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:11 pm

INFA

Informatica has revised its FY24 revenue guidance from a range of $1.685 billion-$1.705 billion to $1.66 billion-$1.68 billion.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:10 pm

LYV

Live Nation Entertainment (NYSE:LYV) reported Q2 2024 GAAP EPS of $1.03, missing the $1.06 estimate, but sales of $6.023B beat the $6.018B estimate. Sales increased by 6.96% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:10 pm

PCRX

Pacira BioSciences has reiterated its full-year 2024 financial guidance, projecting total revenue between $680 million and $705 million, aligning closely with the estimated $694.66 million.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:10 pm

FSLR

First Solar has maintained its FY24 guidance, indicating confidence in its future performance.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:09 pm